Agilent approach of using ACE for Qualification

When Agilent does qualification of any Agilent HPLC/GC/GCMS using Agilent software, Agilent use ACE technology for generating results. From the data integrity point of view in pharmaceutical industry, this is not right as the result has no linkage with raw data. Also we can never identify whether all acquired data has been processed or not?. Can we get some clarification on this approach of Agilent.

Was this helpful?